Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-11-13
1991-06-25
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546116, A61K 31435, C07D491048
Patent
active
050267140
ABSTRACT:
Novel blood sugar-lowering dihydropyridinelactones of the formula ##STR1## in which R represents halogen, C.sub.1 -C.sub.10 -alkyl, C.sub.1 -C.sub.10 -alkoxy, C.sub.1 -C.sub.10 -alkylthio, C.sub.1 -C.sub.10 -alkylsulphinyl, C.sub.1 -C.sub.10 -alkylsulphonyl, cyano, C.sub.1 -C.sub.6 - mono- or polyfluoroalkyl, C.sub.1 -C.sub.6 -mono- or polyfluoroalkoxy or nitro,
REFERENCES:
patent: 4048171 (1977-09-01), Bossert et al.
patent: 4145432 (1979-03-01), Sato
patent: 4253248 (1985-07-01), Franckowiak et al.
Schramm et al., Nature vol. 303, Jun. 9, 1983.
Bischoff Hilmar
Bossert Friedrich
Goldmann Siegfried
Petzinna Dieter
Puls Walter
Bayer Aktiengesellschaft
Fan Jane T.
LandOfFree
Novel 1-alkyl-substituted 1,4-dihydropyridinelactone anti-diabet does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel 1-alkyl-substituted 1,4-dihydropyridinelactone anti-diabet, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel 1-alkyl-substituted 1,4-dihydropyridinelactone anti-diabet will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1040106